CINECA IRIS Institutional Research Information System

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 19 a 38 di 513
Titolo Data di pubblicazione Autore(i) File
Aggressive subtypes of cutaneous T-cell lymphoma subsets: management and prognosis. 2003 BERNENGO M.G.; QUAGLINO P.
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 2006 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML 2015 C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. 1999 BOCCADORO M ;TARELLA C ;PALUMBO A ;ARGENTINO C ;TRIOLO S ;DOMINIETTO A ;CALLEA V ;LAUTA VM ;MOLICA S ;MUSTO P ;MARMONT F ;GIANNI AM ;PILERI A
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. 1999 Boccadoro M; Tarella C; Palumbo A; Argentino C; Triolo S; Dominietto A; Callea V; Lauta VM; Molica S; Musto P; Marmont F; Gianni AM; Pileri A
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins 1999 Tazzari PL; de Totero D; Bolognesi A; Testoni N; Pileri S; Roncella S; Reato G; Stein H; Gobbi M; Stirpe F
An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR 2007 MULLER MC; SAGLIO G; LIN F; PFEIFER H; PRESS RD; TUBBS RR; PASCHKA P; GOTTARDI; E; O'BRIEN SG; OTTMANN OG; STOCKINGER H; WIECZOREK L; MERX K; KNIG H; SCHWINDEL; U; HEHLMANN R; HOCHHAUS A
Analisi genomica del medulloblastoma in pazienti pediatrici 2007 Coco S; Pezzolo A; Capra V; Raso A; Nozza P; Longo L; Cama A; Gambini C; Pistoia V; Sandri A; Basso ME; Aschero S; Forni M; Madon E; Garrè ML; Cinalli G; Andolfo I; Zollo M; Iolascon A; Tonini GP
Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload. 2003 M. De Gobbi;F. Daraio;C. Oberkanins;A. Moritz;F. Kury;G. Fiorelli;C. Camaschella
Analysis of seven ribosomal protein genes in Italian Diamond Blackfan anemia patients 2010 Ramenghi U ;Quarello P ;Garelli E ;Carando A;Lorenzati A ;Ansaldi G;Davitto M ;Boria I; Aspesi A ;Dianzani I
Analysis of the breakpoint cluster region in essential thrombocythemia. 1990 CORRADINI P ;PALUMBO AP ;BATTAGLIO S ;PONZIO G ;BOCCADORO M ;PILERI A
Analysis of the breakpoint cluster region in essential thrombocythemia. 1990 Corradini P; Palumbo A; Battaglio S; Ponzio G; Boccadoro M; Pileri A
Analysis of the carbonyl compounds produced in beta thalassaemic erythrocytes by oxidative stress. 1989 RAMENGHI U; DAVID O; DIANZANI I; SACCHETTI L; BIASI F; CHIARPOTTO E; POLI G
Angiocentric lymphoma: a case report. 1990 DARBESIO A ;FERRERO D
Antitumor vaccination: where we stand. 2000 BOCCHIA M ;BRONTE V ;COLOMBO MP ;DE VINCENTIIS A ;DI NICOLA M ;FORNI G ;LANATA L ;LEMOLI RM ;MASSAIA M ;RONDELLI D ;ZANON P ;TURA S
THE ASSESSMENT OF SOMATIC MUTATIONS IN ACUTE MYELOID LEUKEMIA IN 2017: A PREDICTIVE MODEL 2017 Galimberti S, Salehzadeh S, Cosimini B, Perutelli F, Metelli MR, Macchia L, Grassi S, Ciabatti E, Caracciolo F, Benedetti E, Orciuolo E, Buda G, Consani G, Petrini M
ASSESSMENT OF THYMIC OUTPUT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING 2006 Bruno B; Sfiligoi C; Cena S; Gilestro M; Cimolin L; Sorasio R; Rotta M; Giaccone L; Galletto E; Omede P; Aiuti A; Boccadoro M
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. 2013 Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G.
Assortimento per gli aplotipi del sistema HLA come possibile meccanismo di selezione genetica o zigotica 1969 A. PIAZZA; MATTIUZ P.L.; CEPPELLINI R.
AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN MULTIPLE MYELOMA: THE GITMO EXPERIENCE 2003 Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavaro P; Rotta M; Aitoro G; Corradini P; Todisco E; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Messina M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Mostrati risultati da 19 a 38 di 513
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile